steatotic liver disease - Search News

Order byBest matchMost fresh

News

GSK to buy liver disease drug from Boston Pharmaceuticals

GSK to buy liver disease drug for up to $2 billion

GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm Boston Pharmaceuticals, the British drugmaker said on Wednesday. Efimosfermin, a monthly subcutaneous injection,

Continue reading

· 1d · on MSN

Zacks Investment Research on MSN · 16h

GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug

GSK to acquire Boston’s liver disease candidate efimosfermin in deal worth up to $2bn

European Medical Journal13h

Steatotic Liver Disease and Frailty in Older Adults

Discover a study that offers new insight into the link between frailty and steatotic liver disease in older adults.

12don MSN

Semaglutide found to have shocking benefit for liver disease patients in new study

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

HealthDay on MSN21h

Digestive Disease Week, May 3-6

Digestive Disease Week, the annual meeting sponsored by the American Association for the Study of Liver Diseases, American ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results